Coventry Releases Part Two of its Annual Drug Trends Series

Monday, July 22, 2019 | 530 | 0

Coventry has releases part two of its Annual Drug Trends Series. In part two of the series we provide analysis on the trends experienced within our combined in- and out-of-network channels. Some highlights from the series include:

- 8 of the top 10 therapeutic classes experienced decreases

- Opioids decreased over 2% points from 2017

- Compounds fell out of the top 10 classes in both utilization and cost

Each part in the series is accompanied by a deeper dive into various related topics to address specific trends highlighted in the drug trend series. To find out more, visit the Coventry Blog Page.

Missed editions of the series can be found on our Drug Trends Page.

About Coventry

Coventry is the leading provider of care and cost management solutions for workers' comp, disability and auto insurance carriers, third-party administrators, and self-insured employers. We design best-in-class products and services to help our partners return injured workers to work, to play, and to life as quickly and as cost effectively as possible. We accomplish this by developing and maintaining consultative partnerships with our clients and stakeholders, built on a foundation of trust that supports the claims management process.

CONTACT:

Coventry

info@cvty.com

800.790.8662

###